US Patent 8883979 Anti-prolactin receptor antibody formulations
Patent 8883979 was granted and assigned to Bayer Healthcare on November, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08883979 Anti-prolactin receptor antibody formulations US Patent 8883979 Anti-prolactin receptor antibody formulations
Infobox
Patent Number
0888397900
Patent Number
888397900
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
088839790
Date of Patent
November 11, 2014
0Patent Application Number
138429060
Date Filed
March 15, 2013
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
088839790
Date of Patent
November 11, 2014
0Patent Application Number
138429060
Date Filed
March 15, 2013
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08883979 Anti-prolactin receptor antibody formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08883979
Date of patent
November 11, 2014
Patent application number
13842906
Date Filed
March 15, 2013
Patent primary examiner
Find more entities like US Patent 8883979 Anti-prolactin receptor antibody formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
